175 related articles for article (PubMed ID: 35112451)
1. Evaluating the therapeutic efficacy of radiolabeled BSA@CuS nanoparticle-induced radio-photothermal therapy against anaplastic thyroid cancer.
Zhang C; Chai J; Jia Q; Tan J; Meng Z; Li N; Yuan M
IUBMB Life; 2022 May; 74(5):433-445. PubMed ID: 35112451
[TBL] [Abstract][Full Text] [Related]
2. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.
Zhou M; Chen Y; Adachi M; Wen X; Erwin B; Mawlawi O; Lai SY; Li C
Biomaterials; 2015 Jul; 57():41-9. PubMed ID: 25913249
[TBL] [Abstract][Full Text] [Related]
3. BSA-directed synthesis of CuS nanoparticles as a biocompatible photothermal agent for tumor ablation in vivo.
Zhang C; Fu YY; Zhang X; Yu C; Zhao Y; Sun SK
Dalton Trans; 2015 Aug; 44(29):13112-8. PubMed ID: 26106950
[TBL] [Abstract][Full Text] [Related]
4. Albumin-Bioinspired Gd:CuS Nanotheranostic Agent for In Vivo Photoacoustic/Magnetic Resonance Imaging-Guided Tumor-Targeted Photothermal Therapy.
Yang W; Guo W; Le W; Lv G; Zhang F; Shi L; Wang X; Wang J; Wang S; Chang J; Zhang B
ACS Nano; 2016 Nov; 10(11):10245-10257. PubMed ID: 27791364
[TBL] [Abstract][Full Text] [Related]
5. Development of copper vacancy defects in a silver-doped CuS nanoplatform for high-efficiency photothermal-chemodynamic synergistic antitumor therapy.
Qin Z; Qiu M; Zhang Q; Yang S; Liao G; Xiong Z; Xu Z
J Mater Chem B; 2021 Nov; 9(42):8882-8896. PubMed ID: 34693959
[TBL] [Abstract][Full Text] [Related]
6. Transdermal Photothermal Sterilization and Abscess Elimination Research of BSA-CuS Nanoparticles in vivo.
Zhao Y; Zhao JJ; Guo JX; Liu SQ; Li Y; Wang XY; Li R; Tang HQ; Li ZY; Yang HF; Chen B
ChemMedChem; 2022 Feb; 17(3):e202100570. PubMed ID: 34719851
[TBL] [Abstract][Full Text] [Related]
7. [Photothermal effect of nano-copper sulfide against tongue squamous cell carcinoma].
Chen D; Chen Z; Wang Z; Yang Y; Jiang Y; Hu C
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1843-1849. PubMed ID: 35012917
[TBL] [Abstract][Full Text] [Related]
8. Photothermal effects of CuS-BSA nanoparticles on H22 hepatoma-bearing mice.
Dun X; Liu S; Ge N; Liu M; Li M; Zhang J; Bao H; Li B; Zhang H; Cui L
Front Pharmacol; 2022; 13():1029986. PubMed ID: 36313308
[TBL] [Abstract][Full Text] [Related]
9. CuS@BSA-NB2 Nanoparticles for HER2-Targeted Photothermal Therapy.
Ying M; Li Q; Wu J; Jiang Y; Xu Z; Ma M; Xu G
Front Pharmacol; 2021; 12():779591. PubMed ID: 35126119
[TBL] [Abstract][Full Text] [Related]
10. Strong Near-Infrared Absorbing and Biocompatible CuS Nanoparticles for Rapid and Efficient Photothermal Ablation of Gram-Positive and -Negative Bacteria.
Huang J; Zhou J; Zhuang J; Gao H; Huang D; Wang L; Wu W; Li Q; Yang DP; Han MY
ACS Appl Mater Interfaces; 2017 Oct; 9(42):36606-36614. PubMed ID: 28976189
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis.
Shi H; Yan R; Wu L; Sun Y; Liu S; Zhou Z; He J; Ye D
Acta Biomater; 2018 May; 72():256-265. PubMed ID: 29588255
[TBL] [Abstract][Full Text] [Related]
13. The Ultrasmall Biocompatible CuS@BSA Nanoparticle and Its Photothermal Effects.
Wan X; Liu M; Ma M; Chen D; Wu N; Li L; Li Z; Lin G; Wang X; Xu G
Front Pharmacol; 2019; 10():141. PubMed ID: 30863310
[TBL] [Abstract][Full Text] [Related]
14. Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma.
Cai H; Dai X; Guo X; Zhang L; Cao K; Yan F; Ji B; Liu Y
Acta Biomater; 2021 Jun; 127():276-286. PubMed ID: 33812073
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Bi NSs@BSA Nanoplatform Guided by CT Imaging for Effective Photothermal Therapy.
Zhang X; Liu B; Yao S; Liu Z; Li J
Langmuir; 2022 Nov; 38(46):14355-14363. PubMed ID: 36350293
[TBL] [Abstract][Full Text] [Related]
16. In Vivo and In Vitro Biocompatibility Study of CuS Nanoparticles: Photosensitizer for Glioblastoma Photothermal Therapy.
Li Y; Yang Z; Jalil AT; Saleh MM; Wu B
Appl Biochem Biotechnol; 2023 Jul; 195(7):4084-4095. PubMed ID: 36652089
[TBL] [Abstract][Full Text] [Related]
17. Flexible CuS-embedded human serum albumin hollow nanocapsules with peroxidase-like activity for synergistic sonodynamic and photothermal cancer therapy.
Wang H; Tao J; Xu C; Tian Y; Lu G; Yang B; Teng Z
Nanoscale; 2022 Jul; 14(27):9702-9714. PubMed ID: 35766330
[TBL] [Abstract][Full Text] [Related]
18. Dual-wavelength responsive CuS@COF nanosheets for high-performance photothermal/photodynamic combination treatments.
An Q; Su S; Hu W; Wang Y; Liang T; Li X; Li C
Nanoscale; 2023 Dec; 15(48):19815-19819. PubMed ID: 38051120
[TBL] [Abstract][Full Text] [Related]
19. Photosensitizer-assembled PEGylated graphene-copper sulfide nanohybrids as a synergistic near-infrared phototherapeutic agent.
Wu C; Zhu A; Li D; Wang L; Yang H; Zeng H; Liu Y
Expert Opin Drug Deliv; 2016; 13(1):155-65. PubMed ID: 26559178
[TBL] [Abstract][Full Text] [Related]
20. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
